Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Stock Picking for Charity - 2007 -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (312)	10/26/2007 5:42:30 PM
From: BulbaMan	Read Replies (1) \| Respond to of 397

10/26/07 update The Nasdaq Biotech Index had a decent week, closing Friday up 11.58% YTD (vs. up 8.87% YTD a week ago). But the larger-cap biotech rally did little for the Charity Contest portfolios' median, which finished the week down -7.50% YTD (vs. down -7.96% a week ago). At week's end 10 of the 31 Contest portfolios were in the black YTD, with just the top two contestants beating the NBI. TECHNET's portfolio (up 26.8% YTD) is still in the lead and I'm in second place (up 13.4% YTD). Have a wonderful weekend everyone! Below is the Top Ten list on 10/26/07: 10/26/07 Rank Name Total 1 TECHNET 26,807 2 BULBA 13,427 3 MOPGCW 10,648 4 FILOF 6,462 5 ROBERT 6,296 6 WILDER 5,078 7 FRED 4,742 8 MANNY 3,261 9 PGONEIL 2,569 10 QUID 1,522 BIVN was bought for $5.60 by Genzyme and I set that as the stock price. (All corrections, especially adjustments for splits, greatly appreciated.)